Clinical Trial Update: Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating NWRD08 for HPV-16/18-related cervical HSIL is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Squamous Intraepithelial Lesion

Drugs mentioned

• NWRD08

Snippet

Sponsor: Newish Biotech (Wuxi) Co., Ltd. | Conditions: High-grade Squamous Intraepithelial Lesion (HSIL) | Phase 2 | Status: RECRUITING